Los medicamentos genéricos, entre la propiedad privada y la salud pública

  1. Juberías Sánchez, Antonio
Dirixida por:
  1. José María Caballero Lozano Director

Universidade de defensa: Universidad de Burgos

Fecha de defensa: 09 de novembro de 2012

Tribunal:
  1. Carlos Vattier Fuenzalida Presidente/a
  2. Elena Vicente Domingo Secretario/a
  3. José Miguel Rodríguez Tapia Vogal
  4. Elena de La Cuesta Elósegui Vogal
  5. Carlos Rogel Vide Vogal

Tipo: Tese

Teseo: 348844 DIALNET lock_openRIUBU editor

Resumo

Health authorities will seek the full availability of safe, effective, and quality drugs care for diseases and conditions that affect the community. The high costs associated with the development and commercialization of new molecules, are the source of high drug prices, which increase drug costs borne by society. The existence of generic drug implies cheaper availability but with equal efficacy that innovators, allowing them to act as an effective tool to control pharmaceutical cost supported by national health systems. The generic marketing advantage of the effort and technology used by innovative medicines, this is the key for your lower price. The marketing of generic drugs, show a number of implications for institutions of a private law as property, patent, design, trademark or liability for defects in the product, which will determine the introduction and availability of generics in the pharmaceutical market.